Sakteesh Gurunathan, MD

Academic Hospitalist/ Associate PD IM Residency @usaunivhospital Interests: #MedEd, #MedTwitter #InternalMedicine || Tweets≠Endorsement

[JAMA @JAMA_current]

In the 2026 US #InternalMedicine workforce, non-US-born #physicians accounted for nearly half of board-certified physicians, including substantial shares across subspecialties such as #geriatrics, #nephrology, and #sleep #medicine.

These findings indicate that immigration policy changes could affect workforce capacity in specialties that rely heavily on non-US-born international medical graduates.

https://t.co/Cmimr6FItm

[Sakteesh Gurunathan, MD @SakteeshGuruMD]

@NYULH_GastroHep @DrJordanAxelrad @nyugrossman @DavidHudesmanMD @MarkPochapin Congratulations!!

[Neil Stone @DrNeilStone]

I honestly do love the US but I will never understand why this shit is tolerated

[JAMA @JAMA_current]

H-1B visa–sponsored physicians are twice as prevalent in rural counties and nearly 4 times as common in high-poverty areas, highlighting the potential harm of rising visa costs to health care access.

https://t.co/TwsCbCc4nT

[Sakteesh Gurunathan, MD @SakteeshGuruMD]

@Dr_VishnuKumar @uams_GIHep @MaugarMD @SumantInamdar @shandrawes @MuzaffarAkbar @Jean_Chalhoub @ASGEendoscopy Congratulations!!!!

[Sakteesh Gurunathan, MD @SakteeshGuruMD]

Yet another reason why polypharmacy must be taken seriously!
Excellent work by @DarrenDrittel and William.
Thanks to @AdamFayeMD

[AJG - The American Journal of Gastroenterology @AmJGastro]

In the 📕#RedJournal:

Severe Polypharmacy Increases Risk of Hospitalization Among Older Adults With Inflammatory Bowel Disease
Drittel, et al.

👉 https://t.co/thLy2hkEyZ
@DarrenDrittel @sakteesh @AasmaShaukatMD @AdamFayeMD

[AJG - The American Journal of Gastroenterology @AmJGastro]

In the 📕#RedJournal:

Severe Polypharmacy Increases Risk of Hospitalization Among Older Adults With Inflammatory Bowel Disease
Drittel, et al.

👉 https://t.co/thLy2hkEyZ
@DarrenDrittel @sakteesh @AasmaShaukatMD @AdamFayeMD

[Mount Sinai Division of Gastroenterology @MountSinaiGI]

Every year, @JeanFredericCo1 hosts the GI Division #IBD Retreat to address challenging topics in #IBD. We're proud to keep the tradition going this year at IBD Retreat 2024! Register here to join: https://t.co/W9RDBvqc6U

[Sakteesh Gurunathan, MD @SakteeshGuruMD]

@Dr_VishnuKumar @UpstateGastro @UpstateIM_Res Congrats ji amazing !

[David Hudesman @DavidHudesmanMD]

Huge congrats to @DrJordanAxelrad celebrating the launch of the Axelrad Lab. So proud of all his accomplishments, and can’t wait to see what the future holds. @nyulangone

[Sakteesh Gurunathan, MD @SakteeshGuruMD]

@DavidHudesmanMD @DrJordanAxelrad @nyulangone Congrats Dd. Axelrad.

[Crohn's & Colitis Foundation @CrohnsColitisFn]

Over the past decade, #IBD treatment options have substantially improved. 2 doctors affiliated with the Foundation spoke to
@WebMD on Crohn’s disease treatments: @shannonchangmd from @Nyulangone
and Dr. Thomas Ullman from @MontefioreNYC: https://t.co/Oa4iZNksSh

[Daniel Liebman MD MBA @D_Liebman]

#AravindDiary
A key difference here is an overall lack of individual doctor-patient “ownership”. Doctors generally don’t have their “own” patients, and patients generally don’t select their “own” doctors. There are generally no set clinic appointments or OR schedules. 1/

[Jean-Frederic Colombel @JeanFredericCo1]

New milestone in CD therapy 👍

[HCPLive @HCPLiveNews]

@adamFayeMD gives an update on some new data looking at older #IBD patients. #DDW2023

https://t.co/XMxokcG1Nl

[Shrinivas Bishu @IBDimmunology]

Aging in #IBD is starting to get the attention it deserves! 👇🏾

I am very pleased to present my friend @AdamFayeMD discuss where we’re going @UMichGIHep #GIGrandRounds

When: Tuesday, May 16, 730-830 AM EST
How: https://t.co/v2ikbmsfgx

[David Hudesman @DavidHudesmanMD]

@DrJordanAxelrad moderating and presenting at #DDW23. Immunosuppression does not seem to increase new or recurrent cancers in #IBD patients. @nyulangone @nyugrossman @shannonchangmd

[Sakteesh Gurunathan, MD @SakteeshGuruMD]

Thanks to @DrJordanAxelrad and Dr @CadwellLab #KyungkuJang for the opportunity. Thanks to @DDWMeeting for the chance to present our work and to @AmerGastroAssn for the Fellow abstract award.

[Tadasu Iizumi, MD PhD @tadasu_iizumi]

Splendid presentation by @sakteesh @nyugrossman #AxelradLab @CadwellLab on using organoids to predict responsiveness to Tofacitinib.
@DDWMeeting @AmerGastroAssn
#IBD #Organoids

[Tadasu Iizumi, MD PhD @tadasu_iizumi]

Splendid presentation by @sakteesh @nyugrossman #AxelradLab @CadwellLab on using organoids to predict responsiveness to Tofacitinib.
@DDWMeeting @AmerGastroAssn
#IBD #Organoids

[Sakteesh Gurunathan, MD @SakteeshGuruMD]

@Tadasu_iizumi @nyugrossman @CadwellLab @DDWMeeting @AmerGastroAssn Thank you!